Christopher Senner

Christopher Senner

Director of Finance/CFO at EXELIXIS, INC.

Net worth: 18 M $ as of 31/03/2024

56 year
Health Technology
Consumer Services

Profile

Currently, Christopher J. Senner occupies the position of Chief Financial Officer & Executive Vice President of Exelixis, Inc. Mr. Senner is also on the board of Cortexyme, Inc. He previously occupied the position of Vice President-Finance at Gilead Sciences, Inc. and Chief Financial Officer of Wyeth Pharmaceuticals LLC. Mr. Senner received an undergraduate degree from Bentley University.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
23/02/2024 754,713 ( 0.25% ) 18 M $ 31/03/2024
24/05/2023 0 ( -.--% ) - $ 31/03/2024

Christopher Senner active positions

CompaniesPositionStart
EXELIXIS, INC. Director of Finance/CFO 15/07/2015
QUINCE THERAPEUTICS, INC. Director/Board Member 01/03/2019
All active positions of Christopher Senner

Former positions of Christopher Senner

CompaniesPositionEnd
GILEAD SCIENCES, INC. Corporate Officer/Principal 01/07/2015
Director of Finance/CFO 01/11/2009
Director of Finance/CFO -
See the detail of Christopher Senner's experience

Training of Christopher Senner

Bentley University Undergraduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Christopher Senner's experience

Connections

100 +

1st degree connections

6

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies3
GILEAD SCIENCES, INC.

Health Technology

EXELIXIS, INC.

Health Technology

QUINCE THERAPEUTICS, INC.

Health Technology

Private companies2

Health Technology

Health Technology

See company connections
  1. Stock Market
  2. Insiders
  3. Christopher Senner